Close

Regulus Therapeutics (RGLS) Promotes Mark Deeg to CMO

June 13, 2017 8:34 AM EDT Send to a Friend
Regulus Therapeutics Inc. (NASDAQ: RGLS) today announced the promotion of Dr. Mark Deeg to Chief Medical Officer. Dr. Deeg joined ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login